Novavax
NVAX
129 hedge funds and large institutions have $174M invested in Novavax in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 38 reducing their positions, and 22 closing their positions.
0.18% less ownership
Funds ownership: 2.69% → 2.51% (-0.18%)
8% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 38
5% less capital invested
Capital invested by funds: $184M → $174M (-$9.48M)
9% less funds holding
Funds holding: 142 → 129 (-13)
11% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $1.24M
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
Top Buyers
| 1 |
BlackRock
New York
|
+$28.8M |
| 2 |
D.E. Shaw & Co
New York
|
+$4.81M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.43M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.68M |
| 5 |
Millennium Management
New York
|
+$1.61M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$9.44M |
| 2 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$5.15M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.62M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.48M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.83M |
NVAX Hedge Fund Activity: Q1 2017 in Review
129 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2017, worth a combined $174M — down 5.2% from $184M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of NVAX and 16 opened new positions — a net loss of 6 holders — while 38 trimmed existing stakes and 35 added.
The largest buyer was BlackRock, adding an estimated $28.8M. The largest seller was State Street, cutting an estimated $9.44M.
- 129 institutional investors held Novavax (NVAX) as of Q1 2017, down from 142 in Q4 2016.
- Funds reported $174M of Novavax stock for Q1 2017, down 5.2% quarter-over-quarter.
- 16 funds opened new Novavax positions in Q1 2017 and 22 closed out, a net change of -6 holders.
- The largest Novavax buyer in Q1 2017 was BlackRock, an estimated $28.8M added.
- The largest Novavax seller in Q1 2017 was State Street, an estimated $9.44M sold.
Based on aggregated 13F filings for Q1 2017.